Table 3.
HMOS | Targets/Models | Mucosal Signaling Effects | References |
---|---|---|---|
Acidic | Intestine; NEC model rat | Attenuate TLR4/NF-κB/NLRP3-mediated inflammation and suppress inflammatory signals of IL-1β, IL-6, TNFα to prevent NEC development | [96] |
Mixture (human colostrum isolates) | Immature intestinal tissue; aborted fetuses | Attenuate pathogen-associated molecular pattern-stimulated IL-1β, IL-6, IL-8, MCP-1 expression while promoting MIP-1-δ, MIP-1-β, TIMP-2 and PDGF the mediators of tissue repair | [86] |
Mixture (human milk isolates) | Intestinal epithelial cells in vitro; human | Suppress TNFα and IL-1β induced inflammtory signals of IL-8, MIP-3α and MCP-1 | [91] |
Intestinal epithelial cells in vitro; human | Enhance epithelial differentiation and promote alkaline phosphatase activity | [88] | |
2′FL | Intestinal cells; human, mice, pigs | Attenuate CD14 expression and suppress LPS-induced IL-8 production in ETEC exposed intestinal cells | [87] |
Intestinal epithelial cells in vitro; human | Suppress Campylobactor jejuni-induced mucosal inflammatory signals of IL-1β, IL-8, MIP-2 | [94] | |
Intestinal epithelial cells in vitro; human, mice | Suppress TLR4 expression and TLR4-mediated NF-κB signaling to prevent intestinal inflammation and NEC development | [95] | |
Intestinal epithelial cells in vitro; human | Selectively inhibit CCL20 release from Ag-IgE complex stimulated intestinal cells in a PPARγ independent manner | [97] | |
Intestinal epithelial cells in vitro; human | Induce upregulation of DEFB1 and ZO-1 genes under the peristalsis-mimic shear force and promote tight junction formation | [98] | |
Goblet cells in vitro; human | Induce upregulations of mucus associated genes TFF3 and CHST5 and promote the mucus barrier function | [90] | |
Intestinal epithelial cells in vitro; human | Modulate glycosylation genes of galectin and downregulate ICAM-1 to prevent pathogen adhesion | [93] | |
3′SL | Intestine; IL-10(-/-) colitis mice | Promote colitis severity and modulated mucosal immunity by stimulating CD11c + dendritic cells through TLR4 pathway | [70] |
Intestinal epithelial cells in vitro; human | Induce upregulation of DEFB1 and ZO-1 genes under the peristalsis-mimic shear force and promote tight junction formation | [98] | |
6′SL | Intestinal epithelial cells in vitro | Inhibit chemokine (IL-8 and CCL20) release from Ag-IgE complex stimulated intestinal cells | [97] |
Intestine; human, mice, pigs | Suppress TLR4 expression and TLR4 signaling to prevent NEC development | [95] | |
DSLNT | Intestine; NEC model rat | Attenuate mucosal inflammation by a selectin-independent process to prevent NEC development | [99] |
Abbreviations: DEFB1, defensin β-1; DSLNT, disialyllacto-N-tetraose; ETEC, enterotoxigenic E. coli; MCP1, monocyte chemoattractant protein 1; MIP, macrophage inflammatory protein; NEC, necrotizing enterocolitis; NF-κB, nuclear transcription factor-κB; PDGF, platelet-derived growth factor; TFF3, trefoil factor 3; TIMP-2, tissue inhibitor of metalloproteinase-2; TJP-1, Tight junction protein-1; ZO-1, zonula occludens-1.